AIMS: Reactive oxygen species (ROS) activate multiple signaling pathways involved in cardiac hypertrophy. Since HO-1 exerts potent antioxidant effects, we hypothesized that this enzyme inhibits ROS-induced cardiomyocyte hypertrophy. METHODS: HL-1 cardiomyocytes were transduced with an adenovirus constitutively expressing HO-1 (AdHO-1) to increase basal HO-1 expression and then exposed to 200 microM hydrogen peroxide (H2O2). Hypertrophy was measured using 3H-leucine incorporation, planar morphometry and cell-size by forward-scatter flow-cytometry. The pro-oxidant effect of H2O2 was assessed by redox sensitive fluorophores. Inducing intracellular redox imbalance resulted in cardiomyocyte hypertrophy through transactivation of nuclear factor kappa B (NF-kappaB). RESULTS: Pre-emptive HO-1 overexpression attenuated the redox imbalance and reduced hypertrophic indices. This is the first time that HO-1 has directly been shown to inhibit oxidant-induced cardiomyocyte hypertrophy by a NF-kappaB-dependent mechanism. CONCLUSION: These results demonstrate that HO-1 inhibits pro-oxidant induced cardiomyocyte hypertrophy and suggest that HO-1 may yield therapeutic potential in treatment of.
AIMS: Reactive oxygen species (ROS) activate multiple signaling pathways involved in cardiac hypertrophy. Since HO-1 exerts potent antioxidant effects, we hypothesized that this enzyme inhibits ROS-induced cardiomyocyte hypertrophy. METHODS:HL-1 cardiomyocytes were transduced with an adenovirus constitutively expressing HO-1 (AdHO-1) to increase basal HO-1 expression and then exposed to 200 microM hydrogen peroxide (H2O2). Hypertrophy was measured using 3H-leucine incorporation, planar morphometry and cell-size by forward-scatter flow-cytometry. The pro-oxidant effect of H2O2 was assessed by redox sensitive fluorophores. Inducing intracellular redox imbalance resulted in cardiomyocyte hypertrophy through transactivation of nuclear factor kappa B (NF-kappaB). RESULTS: Pre-emptive HO-1 overexpression attenuated the redox imbalance and reduced hypertrophic indices. This is the first time that HO-1 has directly been shown to inhibit oxidant-induced cardiomyocyte hypertrophy by a NF-kappaB-dependent mechanism. CONCLUSION: These results demonstrate that HO-1 inhibits pro-oxidant induced cardiomyocyte hypertrophy and suggest that HO-1 may yield therapeutic potential in treatment of.
Authors: L E Otterbein; F H Bach; J Alam; M Soares; H Tao Lu; M Wysk; R J Davis; R A Flavell; A M Choi Journal: Nat Med Date: 2000-04 Impact factor: 53.440
Authors: S F Yet; R Tian; M D Layne; Z Y Wang; K Maemura; M Solovyeva; B Ith; L G Melo; L Zhang; J S Ingwall; V J Dzau; M E Lee; M A Perrella Journal: Circ Res Date: 2001-07-20 Impact factor: 17.367
Authors: D R Pimentel; J K Amin; L Xiao; T Miller; J Viereck; J Oliver-Krasinski; R Baliga; J Wang; D A Siwik; K Singh; P Pagano; W S Colucci; D B Sawyer Journal: Circ Res Date: 2001-08-31 Impact factor: 17.367
Authors: S Kinugawa; H Tsutsui; S Hayashidani; T Ide; N Suematsu; S Satoh; H Utsumi; A Takeshita Journal: Circ Res Date: 2000-09-01 Impact factor: 17.367
Authors: Chad D Touchberry; Chris J Elmore; Tien M Nguyen; Jon J Andresen; Xiaoli Zhao; Matthew Orange; Noah Weisleder; Marco Brotto; William C Claycomb; Michael J Wacker Journal: Biochem Biophys Res Commun Date: 2011-11-06 Impact factor: 3.575
Authors: Chad D Touchberry; Troy M Green; Vladimir Tchikrizov; Jaimee E Mannix; Tiffany F Mao; Brandon W Carney; Magdy Girgis; Robert J Vincent; Lori A Wetmore; Buddhadeb Dawn; Lynda F Bonewald; Jason R Stubbs; Michael J Wacker Journal: Am J Physiol Endocrinol Metab Date: 2013-02-26 Impact factor: 4.310
Authors: Genri Kawahara; Molly J Gasperini; Jennifer A Myers; Jeffrey J Widrick; Alal Eran; Peter R Serafini; Matthew S Alexander; Mathew T Pletcher; Carl A Morris; Louis M Kunkel Journal: Hum Mol Genet Date: 2013-11-13 Impact factor: 6.150
Authors: Melissa A Allwood; Brittany A Edgett; Ashley L Eadie; Jason S Huber; Nadya Romanova; Philip J Millar; Keith R Brunt; Jeremy A Simpson Journal: J Physiol Date: 2018-05-13 Impact factor: 5.182
Authors: Jennifer B Rose; Zlatina Naydenova; Andrew Bang; Megumi Eguchi; Gary Sweeney; Doo-Sup Choi; James R Hammond; Imogen R Coe Journal: Am J Physiol Heart Circ Physiol Date: 2009-12-24 Impact factor: 4.733
Authors: Sun Mi Hwang; Yun Jung Lee; Yong Pyo Lee; Jung Joo Yoon; So Min Lee; Jeong Dan Cha; Kyung Min Choi; Dae Gill Kang; Ho Sub Lee Journal: Evid Based Complement Alternat Med Date: 2013-09-12 Impact factor: 2.629